Logo

American Heart Association

  104
  0


Final ID: Su3178

Sex, ethnic and social determinants of health differences in high-potency P2Y12 inhibitors prescription among patients with acute coronary syndrome: An analysis of the American Heart Association Get With The Guidelines®–Coronary Artery Disease Registry

Abstract Body (Do not enter title and authors here): Background: Sex and racial differences in the outcomes of patients with acute coronary syndrome (ACS) persist and could be related to the differences in management including high-potency P2Y12 inhibitors.

Aim: This study aims to examine the contribution of social determinants of health on the association between sex and racial differences in the prescription of high-potency P2Y12 inhibitor upon discharge.

Methods: Patients with ACS undergoing percutaneous coronary intervention (PCI) from the American Heart Association Get With The Guidelines®–Coronary Artery Disease Registry between October 2019 to December 2022 were included. Multivariable hierarchical models were used to assess whether there are differences in high-potency P2Y12 inhibitors (i.e., ticagrelor or prasugrel) prescription at discharge adjusting for race/ethnicity, insurance, age, social vulnerability index (SVI), zip code designation, and medical history. Analyses were performed in women and men separately.

Results: Among 135,153 patients with ACS who underwent PCI, 59.8% were discharged on a high-potency P2Y12 inhibitor. Compared with men, women were less likely prescribed high-potency P2Y12 inhibitor (66.9% vs 72%), and this pattern did not change during the study period (P=0.50) (Figure). There was a significant interaction between sex and race for high-potency P2Y12 inhibitor prescription (P< 0.05). Among women, the likelihood of high-potency P2Y12 inhibitors prescription was not significantly different across different race/ethnicities. However, in men, non-Hispanic Blacks and Hispanics had lower odds of high-potency P2Y12 inhibitors prescription compared with non-Hispanic Whites among men after adjusting for all covariates.

Conclusions: In this large contemporary observational analysis of patients with AMI undergoing PCI, women were less likely prescribed a high-potency P2Y12 inhibitor upon discharge. Among women, the likelihood of high-potency P2Y12 inhibitors prescription was not significantly different across different race/ethnicities; however, in men, non-Hispanic Blacks and Hispanics had lower odds of high-potency P2Y12 inhibitors prescription. Further efforts should be directed to minimize these sex and racial disparities.
  • Mansoor, Hend  ( University of Kentucky , Lexington , Kentucky , United States )
  • Poudel, Remy  ( American Heart Association , Georgetown , Texas , United States )
  • Hong, Haoyun  ( American Heart Association , Georgetown , Texas , United States )
  • Li, Shen  ( American Heart Association , Georgetown , Texas , United States )
  • Thomas, Kathie  ( AMERICAN HEART ASSOCIATION , Grand Rapids , Michigan , United States )
  • Sigal, Stephen  ( HEART VASCULAR INSTITUTE AT TITUS , Mt Pleasant , Texas , United States )
  • Tamis-holland, Jacqueline  ( The Cleveland Clinic , Cleveland , Ohio , United States )
  • Goyal, Abhinav  ( The Emory Clinic , Atlanta , Georgia , United States )
  • Elgendy, Islam  ( University of Kentucky , Lexington , Kentucky , United States )
  • Author Disclosures:
    Hend Mansoor: DO NOT have relevant financial relationships | Remy Poudel: No Answer | Haoyun Hong: DO NOT have relevant financial relationships | Shen Li: DO NOT have relevant financial relationships | Kathie Thomas: DO NOT have relevant financial relationships | Stephen Sigal: DO NOT have relevant financial relationships | Jacqueline Tamis-Holland: DO NOT have relevant financial relationships | Abhinav Goyal: DO NOT have relevant financial relationships | Islam Elgendy: DO NOT have relevant financial relationships
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Bridging the Gap: Social Determinants and Disparities in Cardiovascular Care

Sunday, 11/17/2024 , 03:15PM - 04:15PM

Abstract Poster Session

More abstracts on this topic:
Anticoagulation versus Antiplatelets in Coronary Artery Ectasia and Acute Coronary Syndrome: A Systematic Review and Meta-analysis

Hernandez-pastrana Sarai, Latapi Ruiz Esparza Ximena, Martignoni Felipe, Araiza Diego, Doma Mohamed, Fatima Syeda Rubab, Hemdanieh Maya, Kritya Mangesh, Huang Wilbert, Naji Zahra, Lingamsetty Shanmukh Sai Pavan, Gewehr Douglas

A Polypill Strategy for Lipid Lowering and Anti-Platelet Therapy After Acute Coronary Syndrome: A Pilot Randomized Controlled Trial

Keshvani Neil, Wang Thomas, Pandey Ambarish, Coellar Juan David, Rizvi Syed Kazim, Jain Anand, Bustillo-rubio M. Karina, Segar Matthew, Lokesh Nidhish, Miller James, Yates Sean

More abstracts from these authors:
Older, non-White, Female and Uninsured Patients With a STEMI Are More Likely to be Transported to a non-Cardiac Cath Lab Center by EMS

Patel Parth, Nathan Ashwin, Henry Timothy, Goyal Abhinav, Thomas Kathie, Fanaroff Alexander, Zhao Juan, Gao Zihang, Hong Haoyun, Granger Christopher, Jacobs Alice, Sather Jeffrey, Sigal Stephen, Vaz Igor

Area-Based Social Risk Measures and In-Hospital Mortality: A Comparative Modeling Study in Coronary Artery Disease Patients

Gao Zihang, Jiang Tian, Hong Haoyun, Thomas Kathie, Hall Jennifer, Zhao Juan

You have to be authorized to contact abstract author. Please, Login
Not Available